HLA-A2 Antikörper
-
- Target
- HLA-A2
- Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Unkonjugiert
-
Applikation
- Multiplex Assay (MA)
- Aufreinigung
- The antibody was purified by affinity chromatography.
- Klon
- BB7-2
- Isotyp
- IgG2b kappa
-
anti-HLA-A2 antibody
Reaktivität: Human FACS, IP Wirt: Maus Monoclonal BB7-2 unconjugated
anti-HLA-A2 antibody (PE)Reaktivität: Human FACS Wirt: Maus Monoclonal BB7-2 PE
anti-HLA-A2 antibodyReaktivität: Human FACS, IP, IHC (fro), IHC, Func, IHC (p) Wirt: Maus Monoclonal BB7-2 unconjugated
anti-HLA-A2 antibody (APC)Reaktivität: Human ICFC Wirt: Maus Monoclonal BB7-2 APC
anti-HLA-A2 antibody (Alexa Fluor 700)Reaktivität: Human FACS Wirt: Maus Monoclonal BB7-2 Alexa Fluor 700
anti-HLA-A2 antibody (Pacific Blue)Reaktivität: Human ELISA Wirt: Maus Monoclonal BB7-2 Pacific Blue
anti-HLA-A2 antibody (APC-Cy7)Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal BB7-2 APC-Cy7
anti-HLA-A2 antibody (PE-Cy7)Reaktivität: Human WB Wirt: Maus Monoclonal BB7-2 PE-Cy7
anti-HLA-A2 antibody (PerCP-Cy5.5)Reaktivität: Human IF Wirt: Maus Monoclonal BB7-2 PerCP-Cy5.5
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 0.5 mg/mL
- Buffer
- Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C
- Informationen zur Lagerung
- The antibody solution should be stored undiluted between 2°C and 8°C.
-
- Target
- HLA-A2
- Substanzklasse
- Influenza Protein
- Hintergrund
- HLA-A2 is most common in Northern Asia and North America populations. MHC class I antigens associated with β2-microglobulin are expressed by all human nucleated cells. MHC class I molecules are involved in presentation of antigens to CD8+ T cells, playing an important role in cell-mediated immune responses and tumor surveillance.
-
